Safety and Immunogenicity Study of 2019-nCoV Vaccine (mRNA-1273) for Prophylaxis of SARS-CoV-2 Infection (COVID-19)
Clinical trial NCT04283461 · COMPLETED
Trial details
- NCT number
- NCT04283461
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-16
- Primary completion
- 2022-04-26
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.